Search clinical trials for: SLx-2101

Total 3301 results

Response Pharmaceuticals

Completed

Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension

Hypertension

Germany
Response Pharmaceuticals

Completed

Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension

Hypertension

United Kingdom
Response Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease

Raynaud's Disease

Germany
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102

Hypertension

Korea, Republic of
Ralexar Therapeutics, Inc.

Completed

A Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis | Eczema, Atopic

United States
Ralexar Therapeutics, Inc.

Unknown

Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States, Canada
SparX Biotech(Jiangsu) Co., Ltd.

Not yet recruiting

Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors

Solid Tumors
Universidade Estadual de Ponta Grossa
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Completed

Effect of Increased Improve Time on Adhesive System (RCT)

Clinical Trial

Brazil
NewG Lab Pharma

Active, not recruiting

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Fibrolamellar Carcinoma

Korea, Republic of
Spyryx Biosciences, Inc.

Completed

A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis

Cystic Fibrosis

Canada
Ain Shams University

Completed

Influence of Roxolid Implant Material on the Implant Stability Implant Stability (BLX)

Completely Edentulous Patients

Egypt
Response Pharmaceuticals

Completed

Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides

Hypertriglyceridemia

Germany
Spyryx Biosciences, Inc.

Completed

An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis ((HOPE-1))

Cystic Fibrosis

United Kingdom, Canada, France, Italy, Portugal
Gilead Sciences

Terminated

Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies

Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Indolent Non-Hodgkin's Lymphoma

United States
Herantis Pharma Plc.

Active, not recruiting

Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE) (AdeLE)

Secondary Lymphedema

Finland, Sweden
Meir Medical Center

Completed

EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA (ETSG)

Primary Open Angle Glaucoma

Israel
University of Texas Southwestern Medical Center

Terminated

Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia

Type 1 Hyperlipoproteinemia

United States
Response Pharmaceuticals

Completed

Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia

Hyperlipidemia

United States
Gilead Sciences

Withdrawn

A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia
Ottawa Hospital Research Institute

Completed

The Association of Sex With Guideline-based Perioperative Care in Hip Fracture Surgery

Surgery | Hip Fractures | Anesthesia | Gender Bias
Fundación Universitaria CIEO

Unknown

Arch Dimension and Inclination of the Upper and Lower Incisors Changes

Malocclusion, Angle Class I
Herantis Pharma Plc.

Terminated

A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema

Secondary Lymphedema

Finland
Gilead Sciences

Completed

Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber

Allergic Rhinitis

Austria
Scorpion Therapeutics, Inc.

Recruiting

First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations

Non-Small Cell Lung Cancer | NSCLC | EGFR/HER2 Exon 20 Insertion Mutation

United States, Taiwan
Seelos Therapeutics, Inc.

Withdrawn

SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease ([STRIVE-AD])

Alzheimer's Disease

Australia
Johns Hopkins University
National Institute on Aging (NIA)

Recruiting

HEARS-SLP: Providing SLP-Delivered Hearing Health Care to Individuals With Cognitive Impairment

Cognitive Impairment | Dementia | Hearing Loss

United States
West Virginia University
University of Pittsburgh

Recruiting

Clarifying the Optimal Application of SLT Therapy Trial (COAST)

Glaucoma and Ocular Hypertension

United States, United Kingdom, Canada
Oligomerix, Inc

Active, not recruiting

Phase 1 Study of OLX-07010 in Healthy Adult and Elderly Participants

Alzheimer Disease

United States
Gilead Sciences

Terminated

An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study

Lymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia

United States
Centre Hospitalier Universitaire de Besancon
European Network of Gynaecological Oncological Trial Groups (ENGOT); ARCAGY...

Recruiting

International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer (SENTICOLIII)

Cervical Cancer

Spain, France, Germany, Czechia, Switzerland, China, Japan, Brazil, Italy, Canada, India, Norway, Slovakia
Ablynx, a Sanofi company

Completed

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura (HERCULES)

Acquired Thrombotic Thrombocytopenic Purpura

United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, Switzerland, Turkey, United Kingdom
Pluristem Ltd.

Completed

Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty

Total Hip Arthroplasty | Muscle Injury

Germany
Gilead Sciences

Completed

Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma

Follicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's Lymphoma

United States
Polish Mother Memorial Hospital Research Institute

Completed

A Comparison Study of Feeding Prematures in the Side-lying Position on the Right and Left Side - a Pilot Study.

Bottle Feeding | Premature

Poland
Gilead Sciences

Completed

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)

Follicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)

Japan
Universidade Federal de Pernambuco

Completed

Validation and Reproducibility of the Six-minute Step Test in Individuals With Obstructive Sleep Apnea Treated With CPAP

Obstructive Sleep Apnea

Brazil
Hannah Choe
National Cancer Institute (NCI); Plexxikon

Completed

Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD

Acute Graft Versus Host Disease | Steroid Refractory Graft Versus Host Disease

United States
Northeastern University
National Institute of Nursing Research (NINR)

Completed

Love, Sex & Choices: A Web Series on Mobile Devices to Reduce Black Women's HIV Risk (LSC)

Risk Behavior | HIV | Sexual Behavior | Chlamydia | Women's Role

United States
Gilead Sciences

Completed

Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma

Hodgkin Lymphoma

United States
Dana-Farber Cancer Institute
Gilead Sciences

Terminated

Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Mehmet Yekta

Completed

Comparison of Effectiveness of Nasal CPAP and Nasal IMV in Early Rescue Surfactant Treatment in Preterm Infants

Noninvasive Ventilation for Respiratory Distress Syndrome

Turkey
Response Pharmaceuticals

Completed

A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
Peking University

Unknown

Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant

Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic Leukemia

United States
Gilead Sciences

Completed

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas (DELTA)

Follicular Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Small Lymphocytic Lymphoma

United States, United Kingdom, Italy, Germany, Poland, France
NVP Healthcare

Completed

Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

Healthy Subjects

Korea, Republic of
Response Pharmaceuticals

Completed

Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma and other conditions

United States
University of California, San Diego
National Institute of Mental Health (NIMH)

Completed

Share Safer Sex Counseling Program for Changing Sexual Risk Behaviors in Mexican Female Sex Workers

HIV Infections | Sexually Transmitted Diseases

Mexico
Chordate Medical

Completed

Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis (KOSNAR)

Nasal Congestion | Non-allergic Rhinitis

Finland, Italy, United Kingdom, Greece, Netherlands, Czechia

Search clinical trials for: SLx-2101

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations